Last week, we welcomed three representatives of Shanghai Yusong Biotechnology Co., Ltd. to our offices, building on the conversation that began with Xi Chen’s visit the week before. What started as an introduction is moving into something more concrete, joint plans, a shared roadmap for gamma-cyclodextrin and a clear sense of where the collaboration can go from here.
The deepening relationship is the result of Tamás Vargadi‘s consistent groundwork and it sits on top of something larger. The work CarboHyde does today is connected to the pioneering legacy of József Szejtli, and partnerships like this one are how that legacy keeps moving forward, into new markets, new applications and new collaborations across continents.
Grateful to the Yusong team for making the trip and looking forward to what we can build together on gamma-cyclodextrin and beyond.
